P3 Health Partners Stock Performance
| PIII Stock | USD 0.21 0 1.43% |
The firm owns a Beta (Systematic Risk) of 2.21, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, P3 Health will likely underperform. At this point, P3 Health Partners has a negative expected return of -1.03%. Please make sure to check P3 Health's standard deviation and the relationship between the treynor ratio and day typical price , to decide if P3 Health Partners performance from the past will be repeated sooner or later.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days P3 Health Partners has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The recent confusion may also be a sign of long-lasting up-swing for the firm traders. ...more
1 | Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.4883 subject to Rule 16b-3 | 09/04/2024 |
2 | Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.4898 subject to Rule 16b-3 | 09/06/2024 |
3 | Acquisition by Chicago Pacific Founders Ugp Iii, Llc of 80000 shares of P3 Health at 0.5591 subject to Rule 16b-3 | 09/11/2024 |
4 | SHAREHOLDER ALERT Levi Korsinsky, LLP Initiates Investigation into P3 Health Partners, Inc. | 09/23/2024 |
5 | Insider Trading | 10/01/2024 |
6 | SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Partners, Inc. | 10/10/2024 |
7 | SHAREHOLDER ALERT Levi Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Partners, Inc. | 10/14/2024 |
8 | SHAREHOLDER ALERT Levi Korsinsky, LLP Notifies Investors of an Investigation into P3 Health Partners | 10/29/2024 |
9 | Acquisition by Erin Darakjian of 100000 shares of P3 Health subject to Rule 16b-3 | 11/05/2024 |
10 | What To Expect From P3 Health Partners Inc Q3 2024 Earnings | 11/11/2024 |
11 | P3 Health Partners Inc. Q3 2024 Earnings Call Transcript | 11/13/2024 |
12 | P3 Health Partners Third Quarter 2024 Earnings Revenues Beat Expectations, EPS Lags | 11/15/2024 |
13 | Acquisition by Bacchus Amir of 1000000 shares of P3 Health subject to Rule 16b-3 | 11/19/2024 |
14 | TD Cowen Lowers P3 Health Partners Price Target to 0.25 | 11/21/2024 |
| Begin Period Cash Flow | 18.5 M | |
| Free Cash Flow | -77.9 M |
PIII |
P3 Health Relative Risk vs. Return Landscape
If you would invest 51.00 in P3 Health Partners on August 25, 2024 and sell it today you would lose (30.00) from holding P3 Health Partners or give up 58.82% of portfolio value over 90 days. P3 Health Partners is currently does not generate positive expected returns and assumes 8.1013% risk (volatility on return distribution) over the 90 days horizon. In different words, 72% of stocks are less volatile than PIII, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
P3 Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for P3 Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as P3 Health Partners, and traders can use it to determine the average amount a P3 Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1276
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PIII |
Estimated Market Risk
| 8.1 actual daily | 72 72% of assets are less volatile |
Expected Return
| -1.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average P3 Health is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of P3 Health by adding P3 Health to a well-diversified portfolio.
P3 Health Fundamentals Growth
PIII Stock prices reflect investors' perceptions of the future prospects and financial health of P3 Health, and P3 Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on PIII Stock performance.
| Return On Equity | -0.41 | ||||
| Return On Asset | -0.12 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | (0.08) % | ||||
| Current Valuation | 116.65 M | ||||
| Shares Outstanding | 162.86 M | ||||
| Price To Book | 0.29 X | ||||
| Price To Sales | 0.09 X | ||||
| Revenue | 1.27 B | ||||
| Gross Profit | (7.75 M) | ||||
| EBITDA | (81.07 M) | ||||
| Net Income | (57.77 M) | ||||
| Cash And Equivalents | 63.15 M | ||||
| Cash Per Share | 1.52 X | ||||
| Total Debt | 124.64 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 0.75 X | ||||
| Book Value Per Share | 1.22 X | ||||
| Cash Flow From Operations | (76.03 M) | ||||
| Earnings Per Share | (0.86) X | ||||
| Market Capitalization | 119.41 M | ||||
| Total Asset | 860.97 M | ||||
| Retained Earnings | (367.34 M) | ||||
| Working Capital | (133.35 M) | ||||
About P3 Health Performance
By evaluating P3 Health's fundamental ratios, stakeholders can gain valuable insights into P3 Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if P3 Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if P3 Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | (1.36) | (1.43) | |
| Return On Tangible Assets | (0.30) | (0.31) | |
| Return On Capital Employed | (0.30) | (0.31) | |
| Return On Assets | (0.07) | (0.07) | |
| Return On Equity | (0.41) | (0.43) |
Things to note about P3 Health Partners performance evaluation
Checking the ongoing alerts about P3 Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for P3 Health Partners help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| P3 Health Partners generated a negative expected return over the last 90 days | |
| P3 Health Partners has high historical volatility and very poor performance | |
| P3 Health Partners has some characteristics of a very speculative penny stock | |
| P3 Health Partners has high likelihood to experience some financial distress in the next 2 years | |
| P3 Health Partners currently holds 124.64 M in liabilities with Debt to Equity (D/E) ratio of 0.08, which may suggest the company is not taking enough advantage from borrowing. P3 Health Partners has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about P3 Health's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 1.27 B. Net Loss for the year was (57.77 M) with loss before overhead, payroll, taxes, and interest of (7.75 M). | |
| P3 Health Partners currently holds about 63.15 M in cash with (76.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| P3 Health Partners has a frail financial position based on the latest SEC disclosures | |
| Roughly 23.0% of P3 Health outstanding shares are owned by corporate insiders | |
| Latest headline from thelincolnianonline.com: TD Cowen Lowers P3 Health Partners Price Target to 0.25 |
- Analyzing P3 Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether P3 Health's stock is overvalued or undervalued compared to its peers.
- Examining P3 Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating P3 Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of P3 Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of P3 Health's stock. These opinions can provide insight into P3 Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for PIII Stock analysis
When running P3 Health's price analysis, check to measure P3 Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy P3 Health is operating at the current time. Most of P3 Health's value examination focuses on studying past and present price action to predict the probability of P3 Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move P3 Health's price. Additionally, you may evaluate how the addition of P3 Health to your portfolios can decrease your overall portfolio volatility.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |